KoBioLabs, Inc (KOSDAQ:348150)
5,360.00
-110.00 (-2.01%)
At close: Apr 28, 2026
KoBioLabs Revenue
In the year 2025, KoBioLabs had annual revenue of 69.29B KRW with 1.36% growth. KoBioLabs had revenue of 15.12B in the quarter ending December 31, 2025, a decrease of -14.36%.
Revenue
69.29B
Revenue Growth
+1.36%
P/S Ratio
1.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
104.09B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CHA Vaccine Research Institute | 158.62M |
| TegoScience | 5.94B |
| SunBio,Inc. | 2.17B |
| Cell Biotech | 53.13B |
| Choong Ang Vaccine Laboratory | 39.19B |
| CTCBIO | 123.77B |
| NovMetaPharma | 1.30B |
| Quratis | 2.46B |